Jacobs Levy Equity Management, Inc Amgen Inc Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Amgen Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 228,815 shares of AMGN stock, worth $65.9 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
228,815Holding current value
$65.9 Million% of portfolio
0.3%Shares
14 transactions
Others Institutions Holding AMGN
# of Institutions
3,309Shares Held
429MCall Options Held
8.06MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$15.2 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.3 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.41 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.81 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.68 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $154B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...